NO20074558L - Krystallisasjon og rensing av glykopyrroniumbromid - Google Patents

Krystallisasjon og rensing av glykopyrroniumbromid

Info

Publication number
NO20074558L
NO20074558L NO20074558A NO20074558A NO20074558L NO 20074558 L NO20074558 L NO 20074558L NO 20074558 A NO20074558 A NO 20074558A NO 20074558 A NO20074558 A NO 20074558A NO 20074558 L NO20074558 L NO 20074558L
Authority
NO
Norway
Prior art keywords
diastereoisomers
crystallization
purification
glycopyrronium bromide
solvent
Prior art date
Application number
NO20074558A
Other languages
English (en)
Other versions
NO340220B1 (no
Inventor
Andrew Douglas Baxter
Kenneth Walter Sinden
Stefan Kleinebekel
Original Assignee
Sosei R & D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sosei R & D Ltd filed Critical Sosei R & D Ltd
Publication of NO20074558L publication Critical patent/NO20074558L/no
Publication of NO340220B1 publication Critical patent/NO340220B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/06—Anti-spasmodics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)

Abstract

KRYSTALLISASJON OG RENSNING AV GLYKOPYRRONIUMBROMID En metode for fremstilling av krystallinsk glyk opyrroniumbromid, omfatter reaksjonen av glykopyrroniumbase med metylbromid i et løsningsmiddel, hvor løsningsmidlet er valgt slik at det diastereoisomere forhold av produktet favoriserer R,S og S,R diastereoisomerer over R,R, og S,S diastereoisomerer og separerer de ønskede diastereoisomerer gjennom én eller flere kontrollerte krystallisasjonstrinn. Denne metoden gir et produkt som har en partikkelstørrelse med smal fordeling.
NO20074558A 2005-03-03 2007-09-10 Krystallinsk glykopyrroniumbromid NO340220B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0504463.1A GB0504463D0 (en) 2005-03-03 2005-03-03 Method of crystallisation and purification
PCT/GB2006/000770 WO2006092617A1 (en) 2005-03-03 2006-03-03 Crystallisation and purification of glycopyrronium bromide

Publications (2)

Publication Number Publication Date
NO20074558L true NO20074558L (no) 2007-09-28
NO340220B1 NO340220B1 (no) 2017-03-20

Family

ID=34451780

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074558A NO340220B1 (no) 2005-03-03 2007-09-10 Krystallinsk glykopyrroniumbromid

Country Status (20)

Country Link
US (1) US8846954B2 (no)
EP (1) EP1856041B1 (no)
JP (1) JP5319119B2 (no)
KR (1) KR101267108B1 (no)
CN (1) CN101133021B (no)
AT (1) ATE431337T1 (no)
AU (1) AU2006219727B2 (no)
BR (1) BRPI0609057A2 (no)
CA (1) CA2601129C (no)
DE (1) DE602006006808D1 (no)
DK (1) DK1856041T3 (no)
ES (1) ES2326132T3 (no)
GB (1) GB0504463D0 (no)
IL (1) IL185576A (no)
MX (1) MX2007010729A (no)
NO (1) NO340220B1 (no)
NZ (1) NZ561293A (no)
PT (1) PT1856041E (no)
WO (1) WO2006092617A1 (no)
ZA (1) ZA200707512B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090005577A1 (en) * 2007-06-29 2009-01-01 Nikolai Kraiouchkine Method of producing 1-substituted 3-pyrrolates
WO2010115937A1 (en) * 2009-04-09 2010-10-14 Novartis Ag Process for preparing pyrrolidinium salts
ES2528957T3 (es) * 2010-06-14 2015-02-13 Chiesi Farmaceutici S.P.A. Forma cristalina del cloruro de glicopirronio
CN103159659A (zh) * 2011-12-19 2013-06-19 沈阳药科大学 一种毒蕈碱受体拮抗剂格隆溴铵的制备方法
CN102627595A (zh) * 2012-03-09 2012-08-08 徐奎 一种制备格隆溴铵的方法
EP3473615B1 (en) 2013-02-28 2022-01-19 Journey Medical Corporation Glycopyrrolate salts
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
CN105175304A (zh) * 2013-11-13 2015-12-23 李兴惠 抗胆碱药物格隆溴铵及组合物
US9926270B2 (en) 2014-08-20 2018-03-27 Dermira, Inc. Process for production of glycopyrronium tosylate
CZ2014680A3 (cs) 2014-10-06 2016-04-13 Zentiva, K.S. Způsob přípravy glykopyrronium bromidu
US9925168B2 (en) * 2016-01-22 2018-03-27 Chiesi Farmaceutici S.P.A. Preparation of micronized particles of an antimuscarinic compound by hydrodynamic cavitation
CN107345945B (zh) * 2016-05-05 2019-12-17 辽宁药联制药有限公司 一种拆分格隆溴铵对映体及杂质检查的高效液相色谱方法
PT109445B (pt) 2016-06-08 2018-11-06 Hovione Farm Sa Co-cristais farmacêuticos cristalinos de brometo de glicopirrónio com lactose
CN107915666A (zh) * 2016-10-09 2018-04-17 四川海思科制药有限公司 一种格隆溴铵化合物
WO2022079194A1 (en) 2020-10-14 2022-04-21 Pcas Process for the production of glycopyrronium tosylate
CN113234003B (zh) * 2021-04-23 2024-02-02 广东嘉博制药有限公司 一种格隆溴铵及其制备方法
CN114428131B (zh) * 2021-12-27 2023-09-15 山东泰合医药科技有限公司 一种拆分格隆溴铵中间体的非对映异构体的检测方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2956062A (en) * 1959-02-26 1960-10-11 Robins Co Inc A H Esters of amino alcohols
DK0937041T3 (da) 1996-11-11 2003-08-11 Christian R Noe Anvendelse af et farmaceutisk egnet salt af (3R,2'R)-3-[(cyclopentil-hydroxyphenylacetyl)oxyl]-1,1-dimethyl-pyrrolidinium til fremstilling af et lægemiddel
AT412088B (de) 2002-12-18 2004-09-27 Pharmacon Forschung & Beratung Gmbh Verfahren zur herstellung der r,r oder s,s konfigurierten glycopyrronium-isomere

Also Published As

Publication number Publication date
IL185576A0 (en) 2008-01-06
EP1856041A1 (en) 2007-11-21
KR20070113263A (ko) 2007-11-28
NZ561293A (en) 2010-05-28
EP1856041B1 (en) 2009-05-13
KR101267108B1 (ko) 2013-05-23
HK1104817A1 (en) 2008-01-25
AU2006219727A1 (en) 2006-09-08
BRPI0609057A2 (pt) 2010-02-17
AU2006219727B2 (en) 2010-03-04
CA2601129A1 (en) 2006-09-08
ATE431337T1 (de) 2009-05-15
CA2601129C (en) 2013-04-30
DE602006006808D1 (de) 2009-06-25
IL185576A (en) 2011-11-30
US20080227988A1 (en) 2008-09-18
NO340220B1 (no) 2017-03-20
DK1856041T3 (da) 2009-08-24
MX2007010729A (es) 2007-11-08
US8846954B2 (en) 2014-09-30
CN101133021B (zh) 2011-01-19
ES2326132T3 (es) 2009-10-01
JP5319119B2 (ja) 2013-10-16
GB0504463D0 (en) 2005-04-13
PT1856041E (pt) 2009-07-21
ZA200707512B (en) 2008-11-26
JP2008531674A (ja) 2008-08-14
WO2006092617A1 (en) 2006-09-08
CN101133021A (zh) 2008-02-27

Similar Documents

Publication Publication Date Title
NO20074558L (no) Krystallisasjon og rensing av glykopyrroniumbromid
NO20082266L (no) Nye 1-azabicykloalkylderivater for behandling av psykotiske og neurodegenerative forstyrrelser
TW200613274A (en) Organic compounds
EP1854863A4 (en) FLUORESCENT AND ITS MANUFACTURING METHOD AND ITS USE
WO2007109654A3 (en) Docetaxel polymorphs and processes
EP1484384A4 (en) PROCESS FOR PREPARING BIOFUEL
IL183700A0 (en) Process for production of (4,5-dihydroisoxazol-3-yl)thio-carboxamidine salts
PL1670778T3 (pl) Przegrupowane pentanole, sposób ich wytwarzania i ich zastosowanie jako środków hamujących zapalenia
EG25356A (en) Process for producing condensed-phase product formone or more gas-phase reactants.
ATE501153T1 (de) Kristallisation von festen formen von clopidogreladditionssalzen
WO2004056769A3 (en) Synthesis of amines and intermediates for the synthesis thereof
WO2008089005A3 (en) Renin inhibitors
EP1614774A4 (en) PROCESS FOR PRODUCING A SINGLE CRYSTAL
NO20045233L (no) Nye krystallinske former av ondansetron, prosesser for deres fremgangsmate, farmasoytiske sammensetninger inneholdende de nye formene og metode for a behandle nausea ved anvendelse
WO2006061215A3 (de) 2-alkyl-cycloalk(en)yl-carboxamide
TNSN07133A1 (en) Heteroatoms-containing tricyclic compounds
IL178880A0 (en) Method for continuously producing granulated fertilizer
WO2006063667A3 (de) Verfahren zur kontinuierlichen herstellung von amino-gruppen tragenden silicium-verbindungen
EP1679392A4 (en) PROCESS FOR PRODUCING MONOCRYSTAL
TW200708512A (en) Crystal of aminopyrrolidine derivative and production method thereof
EP1698703A4 (en) PROCESS FOR DIPEPTIDE PRODUCTION
WO2007116011A3 (de) Substituierte triazolopyrimidine, verfahren zu ihrer herstellung und ihre verwendung zur bekämpfung von schadpilzen sowie sie enthaltende mittel
NO20092214L (no) Krystallinske former av aryl-substituerte pyrazol-amid forbindelser
UA91565C2 (en) Thiazols, use of thiazols as fungicides
DK1570748T3 (da) Foderpellets baseret på naturmaterialer og fremgangsmåde til fremstilling af dem

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: SOSEI R&D LTD., GB

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: HEPTARES THERAPEUTICS LIMITED, GB